Condom type | PU A | Latex C | Difference (%) | 2-sided 95% CI | Null hypothesis |
---|---|---|---|---|---|
Primary analysis: polyurethane A versus Control Latex C | |||||
Couples | 252 | 252 | – | – | – |
Condoms used | 1193 | 1212 | – | – | – |
Total clinical failure (%) | 28 (2.35) | 16 (1.32) | 1.03 | (− 0.29, 2.35) | Rejected1 |
Clinical breakage (%) | 15 (1.26) | 10 (0.83) | 0.43 | (− 0.61, 1.48) | Rejected2 |
Clinical slippage (%) | 13 (1.09) | 6 (0.50) | 0.59 | (− 0.19, 1.38) | Rejected2 |
Primary analysis: polyurethane B versus control latex C | |||||
Couples | 247 | 247 | – | – | – |
Condoms used | 1142 | 1193 | – | – | – |
Total clinical failure (%) | 35 (3.06) | 15 (1.26) | 1.81 | (0.39, 3.23) | Fail to Reject1 |
Clinical breakage (%) | 22 (1.93) | 9 (0·75) | 1.17 | (− 0.03, 2.37) | Fail to Reject2 |
Clinical slippage (%) | 13 (1.14) | 6 (0.50) | 0.64 | (− 0.14, 1.41) | Rejected2 |
Post Hoc analysis: polyurethane B versus latex C with male partners penis length ≤ 170 mm | |||||
Couples | 190 | 190 | |||
Condoms used | 886 | 915 | |||
Total clinical failure (%) | 20 (2.26) | 11 (1.20) | 1.06% | (− 0.26, 2.37) | Rejected1 |
Clinical breakage (%) | 12 (1.35) | 5 (0.55) | 0.81% | (− 0.23, 1.84) | Rejected2 |
Clinical slippage (%) | 8 (0.90) | 6 (0.66) | 0.25% | (− 0.57, 1.06) | Rejected2 |